# Healthier Choices Management Corp.: overview HCMC · OTC · CIK 844856 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/hcmc.md) · [Financials](/companies/hcmc/financials.md) · [Filings](/companies/hcmc/filings.md) · [Insiders](/companies/hcmc/insiders.md) Latest reported revenue: [$0](/filings/0001493152-26-013232.md) for Q4 FY2025, three months to 2025-12-31, from the 10-K filed Mar 27, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001493152-26-013232). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [0.1](/filings/0001493152-25-021113.md) | [0.2 d](/filings/0001493152-26-013232.md) | [1.8](/filings/0001493152-26-022965.md) | [1.0](/filings/0001493152-26-039201.md) | [0.2](/filings/0001493152-25-021113.md) | [0.0 d](/filings/0001493152-26-013232.md) | not reported | not reported | | Gross margin | % | [71.2%](/filings/0001493152-25-021113.md) | [(42602.6%) d](/filings/0001493152-26-013232.md) | [17.0%](/filings/0001493152-26-022965.md) | [(2283.4%)](/filings/0001493152-26-039201.md) | [100.0%](/filings/0001493152-25-021113.md) | not reported | not reported | not reported | | Operating margin | % | [(4121932.7%)](/filings/0001493152-25-021113.md) | [(1404512.2%) d](/filings/0001493152-26-013232.md) | [(121877.1%)](/filings/0001493152-26-022965.md) | [(200361.0%)](/filings/0001493152-26-039201.md) | [(1047737.2%)](/filings/0001493152-25-021113.md) | not reported | not reported | not reported | | Net margin | % | [(8359675.0%)](/filings/0001493152-25-021113.md) | [(1394864.7%) d](/filings/0001493152-26-013232.md) | [(122678.4%)](/filings/0001493152-26-022965.md) | [(199179.7%)](/filings/0001493152-26-039201.md) | [(1043272.9%)](/filings/0001493152-25-021113.md) | not reported | not reported | not reported | | Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Free cash flow | $k | [438 d](/filings/0001493152-25-021113.md) | [(1,622) d](/filings/0001493152-26-013232.md) | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL not reported. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [13.3](/filings/0000844856-23-000010.md) | [29.3](/filings/0001493152-24-011537.md) | [0.0](/filings/0001641172-25-004607.md) | [0.0](/filings/0001493152-26-013232.md) | [0.0](/filings/0001493152-26-013232.md) | | Gross margin | % | [39.7%](/filings/0000844856-23-000010.md) | [34.9%](/filings/0001493152-24-011537.md) | [(27.6%)](/filings/0001641172-25-004607.md) | [(13234.5%)](/filings/0001493152-26-013232.md) | [(937.9%)](/filings/0001493152-26-013232.md) | | Operating margin | % | [(35.6%)](/filings/0000844856-23-000010.md) | [(29.6%)](/filings/0001493152-24-011537.md) | [(1207716.2%)](/filings/0001641172-25-004607.md) | [(1697351.3%)](/filings/0001493152-26-013232.md) | [(236084.2%)](/filings/0001493152-26-013232.md) | | Net margin | % | [(30.3%)](/filings/0000844856-23-000010.md) | [(24.7%)](/filings/0001493152-24-011537.md) | [(2995604.5%)](/filings/0001641172-25-004607.md) | [(2373421.8%)](/filings/0001493152-26-013232.md) | [(235580.6%)](/filings/0001493152-26-013232.md) | | Diluted EPS | $ per share | [0.00](/filings/0000844856-23-000010.md) | [0.00](/filings/0001493152-24-011537.md) | [0.00](/filings/0001493152-24-011537.md) | not reported | not reported | | Free cash flow | $m | [(3.6)](/filings/0000844856-23-000010.md) | [(4.3)](/filings/0001493152-24-011537.md) | [(4.9)](/filings/0001641172-25-004607.md) | [(3.7)](/filings/0001493152-26-013232.md) | not reported | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/hcmc/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [CHICAGO TRUST Co NA](/funds/1601539.md) | 2026-06-30 | $50 | 1,010,000 | | Unchanged | | [Vermillion Wealth Management, Inc.](/funds/1737012.md) | 2026-06-30 | $25 | 500,000 | | New +500,000 | | [PROATHLETE WEALTH MANAGEMENT LLC](/funds/2012065.md) | 2026-06-30 | $2 | 50,000 | | Unchanged | | [MassMutual Private Wealth & Trust, FSB](/funds/1103653.md) | 2026-06-30 | $1 | 12,000 | | Unchanged | | [RMG Wealth Management LLC](/funds/1844731.md) | 2026-06-30 | $0 | 464,000 | | New +464,000 | | [Wealth Group Ltd](/funds/2010748.md) | 2026-06-30 | $0 | 170,000 | | Unchanged | | [HANTZ FINANCIAL SERVICES, INC.](/funds/1071061.md) | 2026-06-30 | $0 | 1,111,111 | | New +1,111,111 | ## Recent filings [All 585 filings](/companies/hcmc/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-19 | 16:04 ET | [10-Q](/filings/0001493152-26-039201.md) | Quarterly report, period 2026-06-30 | 0001493152-26-039201 | | 2026-05-14 | 14:14 ET | [10-Q](/filings/0001493152-26-022965.md) | Quarterly report, period 2026-03-31 | 0001493152-26-022965 | | 2026-04-03 | 06:13 ET | [8-K/A](/filings/0001493152-26-015032.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-015032 | | 2026-04-03 | 21:29 ET | [8-K](/filings/0001493152-26-015019.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-26-015019 | | 2026-03-27 | 16:52 ET | [10-K](/filings/0001493152-26-013232.md) | Annual report, period 2025-12-31 | 0001493152-26-013232 | | 2025-11-06 | 17:30 ET | [10-Q](/filings/0001493152-25-021113.md) | Quarterly report, period 2025-09-30 | 0001493152-25-021113 | | 2025-11-06 | 13:17 ET | [8-K/A](/filings/0001493152-25-021023.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-021023 | | 2025-08-13 | 16:34 ET | [10-Q](/filings/0001641172-25-023521.md) | Quarterly report, period 2025-06-30 | 0001641172-25-023521 | | 2025-05-13 | 15:40 ET | [10-Q](/filings/0001641172-25-009926.md) | Quarterly report, period 2025-03-31 | 0001641172-25-009926 | | 2025-04-24 | 16:00 ET | [8-K/A](/filings/0001641172-25-005996.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-005996 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001493152-26-013232.md), filed Mar 27, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 844856 - Tickers: HCMC - Exchange: OTC - SIC code: 2100 Tobacco Products - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.